The global nucleic acid pharmaceuticals utilizing microrna (mirna) market is undergoing a significant transformation, driven by rapid progress in RNA-based therapeutics and a growing shift toward precision medicine. In 2025, the market was valued at USD 598.38 million, reflecting its early-stage yet fast-developing nature. Over the forecast period from 2026 to 2038, the market is expected to...